Translate Bio

Translate Bio appoints Ann Barbier as Chief Medical Officer

Monday, November 6, 2017

Translate Bio, a biotechnology company focused on pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases, announced the appointment of Ann Barbier, M.D., Ph.D., as chief medical officer, effective immediately. Dr. Barbier brings nearly 20 years of drug discovery and development experience to Translate Bio, and will be responsible for leading all clinical research and development, medical affairs and related functions at Translate Bio.

[Read More]

RaNA Therapeutics relaunches as Translate Bio

Monday, July 3, 2017

RaNA Therapeutics has relaunched as Translate Bio (www.translate.bio). The new name stems from the company’s focus on pioneering the translation of RNA science into therapeutics promoting healthy gene expression for people living with debilitating genetic diseases. In addition to its new name, the company also announced the recent leadership appointments of Michael Heartlein, Ph.D., as chief technical officer and Brian Fenton as chief business officer.

[Read More]